Objective:

To evaluate the management strategies for idiopathic acute pancreatitis (IAP) and the role of genetic testing, cholecystectomy, and ERCP, particularly in the context of varying guidelines.

Key Findings:

• Genetic testing can identify pathogenic variants in patients with IAP and IRAP, especially in younger patients.
• Empiric cholecystectomy may reduce recurrence rates, particularly when occult biliary disease is identified, though evidence is mixed.
• Routine ERCP is not recommended for IAP due to associated risks and limited benefits.

Interpretation:

Genetic testing and selective surgical interventions can significantly impact the management of idiopathic acute pancreatitis, but guidelines vary on their application, highlighting the need for individualized approaches.

Limitations:

• Genetic testing may face issues like incomplete gene coverage, cost barriers, and psychosocial implications.
• Evidence for cholecystectomy is mixed, with small sample sizes affecting statistical significance.

Conclusion:

Careful evaluation and tailored management strategies, including genetic testing and selective surgical interventions, can help reduce recurrence in idiopathic acute pancreatitis, emphasizing the importance of individualized patient assessments.